Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan van Lunzen

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
AIDS Reviews|January 26, 2008
Treatment of heavily antiretroviral-experienced HIV-infected patientsJan van Lunzen
European Journal of Medical Research|October 16, 2007
How will CCR5 antagonists influence the recommendations for the antiretroviral treatment of HIV-1 infectionJan van Lunzen
The Journal of Infectious Diseases|June 27, 2014
Sex differences in infectious diseases-common but neglectedJan van Lunzen, Marcus Altfeld
Current Opinion in HIV and AIDS|April 18, 2009
Virological rebound and its consequences during treatment interruptionJan van Lunzen, Christian Hoffmann
Current HIV/AIDS Reports|February 19, 2011
Gene therapy strategies: can we eradicate HIV?Jan van Lunzen, Boris Fehse, Joachim Hauber
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 26, 2012
Stereoselective synthesis of D- and L-carbocyclic nucleosides by enzymatically catalyzed kinetic resolutionMiriam Mahler, Bastian Reichardt, Philip Hartjen, et al.
Deutsche Medizinische Wochenschrift (1946)|September 12, 2015
[Sex differences in infectious diseases and their clinical consequences]Claudia Beisel, Jan van Lunzen, Ansgar W Lohse, et al.
AIDS (London, England)|September 10, 2003
Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetrationChristian Eggers, Kurt Hertogs, Hans-Jörg Stürenburg, et al.
AIDS Research and Human Retroviruses|June 9, 2009
Preferential upregulation of interferon-alpha subtype 2 expression in HIV-1 patientsC Lehmann, D Taubert, N Jung, et al.
Viruses|October 14, 2011
Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case ReportKnud Schewe, Christian Noah, Hüseyin Sirma, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
AIDS Reviews|January 26, 2008
Treatment of heavily antiretroviral-experienced HIV-infected patientsJan van Lunzen
European Journal of Medical Research|October 16, 2007
How will CCR5 antagonists influence the recommendations for the antiretroviral treatment of HIV-1 infectionJan van Lunzen
The Journal of Infectious Diseases|June 27, 2014
Sex differences in infectious diseases-common but neglectedJan van Lunzen, Marcus Altfeld
Current Opinion in HIV and AIDS|April 18, 2009
Virological rebound and its consequences during treatment interruptionJan van Lunzen, Christian Hoffmann
Current HIV/AIDS Reports|February 19, 2011
Gene therapy strategies: can we eradicate HIV?Jan van Lunzen, Boris Fehse, Joachim Hauber
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 26, 2012
Stereoselective synthesis of D- and L-carbocyclic nucleosides by enzymatically catalyzed kinetic resolutionMiriam Mahler, Bastian Reichardt, Philip Hartjen, et al.
Deutsche Medizinische Wochenschrift (1946)|September 12, 2015
[Sex differences in infectious diseases and their clinical consequences]Claudia Beisel, Jan van Lunzen, Ansgar W Lohse, et al.
AIDS (London, England)|September 10, 2003
Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetrationChristian Eggers, Kurt Hertogs, Hans-Jörg Stürenburg, et al.
AIDS Research and Human Retroviruses|June 9, 2009
Preferential upregulation of interferon-alpha subtype 2 expression in HIV-1 patientsC Lehmann, D Taubert, N Jung, et al.
Viruses|October 14, 2011
Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case ReportKnud Schewe, Christian Noah, Hüseyin Sirma, et al.
Pageof 12